H. pylori Treatment: How This Common Infection Is Treated

Helicobacter pylori is one of the most common chronic bacterial infections in the world, quietly colonizing the stomach lining of an estimated half of the global population, often for decades without producing a single symptom. What eventually brings it to medical attention — persistent indigestion, an ulcer, or an unexplained iron deficiency — is only the visible tip of a much longer, largely silent relationship between this bacterium and the stomach lining it has adapted specifically to survive in.

How a Bacterium Survives the Stomach's Acid

Most bacteria can't survive stomach acid, which is precisely why H. pylori is so biologically unusual: it produces an enzyme called urease that converts urea into ammonia, neutralizing acid in its immediate surroundings and creating a small protected pocket within the mucus layer lining the stomach wall. From that sheltered position, it can persist indefinitely unless specifically treated, gradually provoking a low-grade inflammatory response in the surrounding tissue that, over years, can lead to gastritis, ulcers, or in a small proportion of long-term carriers, an increased risk of stomach cancer.

Why Most Infections Stay Silent

The majority of people carrying H. pylori never develop noticeable symptoms, and researchers don't yet fully understand why the same bacterium causes significant disease in some people and remains harmless in others — factors likely include the specific strain involved, genetic differences in the host's inflammatory response, and other lifestyle factors such as diet and smoking. This variability is part of why testing is generally reserved for people with a specific reason to suspect infection, such as ongoing upper digestive symptoms, a diagnosed ulcer, or a family history of stomach cancer, rather than broad population-wide screening.

How the Infection Is Actually Diagnosed

Several reliable testing methods exist, each with different practical trade-offs. A urea breath test, which detects the byproducts of the bacterium's own urease enzyme, is non-invasive and widely used, as is a stool antigen test that directly detects H. pylori proteins in a stool sample. Blood antibody tests are less favored for confirming an active infection, since antibodies can remain detectable long after successful treatment, making them more useful for past-exposure screening than for confirming current infection. Endoscopy with a tissue biopsy is generally reserved for cases where a doctor already needs to examine the stomach lining directly for other reasons, such as investigating an ulcer.

Why Treatment Requires Multiple Medications at Once

Unlike many bacterial infections treated with a single antibiotic, H. pylori is generally treated with a combination of two antibiotics plus an acid-suppressing medication, typically a proton pump inhibitor, taken together for one to two weeks. This combination approach exists because the bacterium has developed meaningful antibiotic resistance in many regions, and using a single antibiotic alone carries a substantially higher risk of treatment failure and further resistance developing. The acid-suppressing component isn't just for symptom comfort — reducing stomach acidity is thought to improve how effectively the antibiotics reach and act on the bacterium within its protected niche.